Journal Report

Expert Opinion on Investigational Drugs

Download PDF
Journal Information
Journal Title
Expert Opinion on Investigational Drugs
Publisher
Taylor and Francis Ltd.
ISSN
1354-3784
E-ISSN
1744-7658
Database
SCOPUS
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Emerging synthetic biology toolkits to control gene expression and provide therapeutic avenues in cardiovascular disease
Ying-Chou Chen, Sahas Pokharel, N. Reed Alexander et al.
2026-11-13 Pages 1-11
DOI: 10.1080/13543784.2026.2761884
Are we moving forward from amisulpride? LB-102 ( <i>N-</i> methyl amisulpride) in acute schizophrenia
Sheila A. Doggrell
2026-11-11 Pages 1-5
DOI: 10.1080/13543784.2026.2761879
Targeted KIT inhibitors: paradigm shift in the treatment of systemic mastocytosis
Hussein A. Abbas, Helen T. Chifotides, Prithviraj Bose
2026-11-10
DOI: 10.1080/13543784.2026.2761888
Targeting MUC1 in colorectal cancer
Yier Lu, Ning Zhu, Ying Yuan
2026-11-3 Pages 1-4
DOI: 10.1080/13543784.2026.2754908
Designing for success in early-phase hemophilia clinical trials: historical lessons and emerging principles for next-generation therapeutics
Johnny N. Mahlangu
2026-10-28 Pages 1-14
DOI: 10.1080/13543784.2026.2754085
Zovegalisib for <i>PIK3CA</i> -driven vascular and lymphatic malformations: a drug evaluation
Emmanuel Seront, An Van Damme, Julien Coulie et al.
2026-10-17 Pages 1-8
DOI: 10.1080/13543784.2026.2750463
Targeting the proteasome in <i>Leishmania donovani</i> : developments from preclinical to Phase I and II trials
Shyam Sundar, Sarita Singh, Priya Maurya et al.
2026-10-3 Vol. 35 Issue 10 Pages 735-750
DOI: 10.1080/13543784.2026.2750461
Dual antigen targeting in extramedullary multiple myeloma
Binish Javed, Shaji Kumar
2026-10-3 Vol. 35 Issue 10 Pages 685-689
DOI: 10.1080/13543784.2026.2746598
Evaluating early systemic therapies in the neoadjuvant setting for the treatment of urological cancers
Panagiotis Velissarios Stamatakos, Charalampos Fragkoulis, Nikolaos Kontolatis et al.
2026-10-3 Vol. 35 Issue 10 Pages 705-714
DOI: 10.1080/13543784.2026.2748359
Safety, pharmacokinetics, pharmacodynamics and target-mediated drug disposition modeling of TST002, a sclerostin antibody, in men and postmenopausal women with low bone mineral density
Sufeng Zhou, Xiufen Zhu, Yuchen Sheng et al.
2026-9-22 Vol. 35 Issue 10 Pages 751-765
DOI: 10.1080/13543784.2026.2736007
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 14, 2026 19:58